EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Clinical trial on new migraine drug shows promising results
news

Clinical trial on new migraine drug shows promising results

HOUSTON - Clinical trials on a drug that prevents migraines are showing promising results. Researchers are testing an antibody that basically attacks the molecule tha...
Continue Reading →
news

FDA approves large-scale clinical trials of ecstasy to treat patients with PTSD

US scientists will treat 230 patients with the rave drug ecstasy aka MDMA  MDMA is classed Class A (Schedule 1 in the US) alongside heroin and LSD  It is known...
Continue Reading →
Patient participation in clinical trials
news

Patient participation in clinical trials

Clinical trials are crucial to help doctors and scientists understand how to safely treat a particular condition, to evaluate new treatments and to test drug safety a...
Continue Reading →
news

DuPont Industrial Biosciences to Begin New Research Aimed to Enable Global Access for Protein Medications

Gates Foundation Grant to address market need for high volume, affordable and rapid cycle time pharmaceutical proteins.   WILMINGTON, Del., Dec. 15, 2016 — DuPon...
Continue Reading →
news

Why pharmaceutical companies should still be preparing for EU General Data Protection Regulation in the New Year – regardless of Brexit

Don’t give up on data reforms just because UK is quitting Europe Pharmaceutical companies are being told to think twice before cancelling or delaying preparations for...
Continue Reading →
Oxford BioDynamics presents applications of its epigenetic biomarker technology EpiSwitchTM at the annual meeting of the American Society of Hematology (ASH) in San Diego
news

Oxford BioDynamics presents applications of its epigenetic biomarker technology EpiSwitchTM at the annual meeting of the American Society of Hematology (ASH) in San Diego

12th December 2016 - Oxford BioDynamics Plc (AIM: OBD), a revenue-generating biotechnology company focused on the discovery and development of novel epigenetic biomar...
Continue Reading →
Europital introduced PenThu® at the Clinical Operations in Oncology Trials event
news

Europital introduced PenThu® at the Clinical Operations in Oncology Trials event

Gent, Belgium: 12th December 2016 –   Europital participated at the “Clinical Operations in Oncology Trials Europe 2016” that was held the 29th and 30th of November i...
Continue Reading →
news

Unique results show DiviTum™ is able to evaluate the anti-tumor activity of blockbuster cancer drug

[Uppsala, Sweden, December 12, 2016] - New clinical study results presented at the San Antonio Breast Cancer Symposium, the world’s leading breast cancer conference,...
Continue Reading →
ERT Acquires Exco InTouch
news

ERT Acquires Exco InTouch

Combination delivers end-to-end eCOA, patient engagement and digital health solutions to better serve customers PHILADELPHIA – December 8, 2016 –– ERT, a leading prov...
Continue Reading →
news

WHAT SOLUTIONS DO GOVERNMENT AND OPPOSITION PARTIES HAVE FOR LONG-TERM HEALTH FUNDING AND PLANNING?

The House of Lords Committee on the Long-Term Sustainability of the NHS will next week take evidence from a star line-up of witnesses including Health Secretary The R...
Continue Reading →
Quotient